HopeStage
Back to all studies
RecruitingNCT06976840

Mood and brain changes during noninvasive stimulation for depression

About this titleRead the official source — NCT06976840
Device studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

What will I do during this study?

Participants complete three TBS sessions one week apart: iTBS, cTBS and sham (simulated). The study varies the stimulation target between two brain networks and measures brain activity with MRI (magnetic resonance imaging) after each session. Mood is rated during the scans and through daily remote check-ins for a week.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 15, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
200
Sponsor
Marta Peciña, MD PhD
Sponsor type
Individual investigator
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT06976840
Official title
Show the full official title

Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments

Recruitment & locations

Currently recruiting

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Marta Peciña, MD PhD.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies